» Articles » PMID: 33632337

Expression Analysis of Tissue Factor Pathway Inhibitors TFPI-1 and TFPI-2 in Paralichthys Olivaceus and Antibacterial and Anticancer Activity of Derived Peptides

Overview
Journal Vet Res
Publisher Biomed Central
Date 2021 Feb 26
PMID 33632337
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue factor pathway inhibitors (TFPI), including TFPI-1 and TFPI-2, are Kunitz-type serine protease inhibitors that mainly inhibit the blood coagulation induced by tissue factors. Previous reports on teleost proved TFPI play important roles in innate immunity. In this study, two TFPI (PoTFPI-1 and PoTFPI-2) molecules from Japanese flounder (Paralichthys olivaceus) were analyzed and characterized for their expression patterns, antibacterial and anticancer activities of the C-terminal derived peptides. Quantitative real time RT-PCR analysis shows that constitutive PoTFPI-1 expression occurred, in increasing order, in the brain, muscle, spleen, gills, head kidney, blood, intestine, heart, and liver; PoTFPI-2 was expressed, in increasing order, in the brain, gills, head kidney, muscle, intestine, spleen, liver, heart, and blood. Under the stimulation of fish pathogens, both PoTFPI-1 and PoTFPI-2 expressions increased significantly in a manner that depended on the pathogens, tissue type, and infection stage. Furthermore, C-terminal peptides TP25 and TP26, derived from PoTFPI-1 and PoTFPI-2, respectively, were synthesized and proved to be active against Micrococcus luteus (for TP25 and TP26) and Staphylococcus aureus (for TP25) via retardation effects on bacterial nucleic acids. In addition, TP25 and TP26 also displayed significant inhibitory effects on human colon cancer cell line HT-29. These results reveal that both PoTFPI-1 and PoTFPI-2 play important roles in host innate immunity. The antibacterial activity and anticancer cells function of TP25 and TP26 will add new insights into the roles of teleost TFPI.

Citing Articles

A novel family of defensin-like peptides from Hermetia illucens with antibacterial properties.

Fahmy L, Generalovic T, Ali Y, Seilly D, Sivanesan K, Kalmar L BMC Microbiol. 2024; 24(1):167.

PMID: 38755524 PMC: 11097590. DOI: 10.1186/s12866-024-03325-1.


Long Non-Coding RNAs: Bridging Cancer-Associated Thrombosis and Clinical Outcome of Ovarian Cancer Patients.

Marques I, Tavares V, Savva-Bordalo J, Rei M, Liz-Pimenta J, de Melo I Int J Mol Sci. 2024; 25(1).

PMID: 38203310 PMC: 10778953. DOI: 10.3390/ijms25010140.


Tuna trimmings hydrolysate alleviates immune stress and intestinal mucosal injury during chemotherapy on mice and identification of potentially active peptides.

Zhao X, Cai B, Chen H, Wan P, Chen D, Ye Z Curr Res Food Sci. 2023; 7:100547.

PMID: 37522134 PMC: 10371818. DOI: 10.1016/j.crfs.2023.100547.


Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia.

Kobayashi H, Matsubara S, Yoshimoto C, Shigetomi H, Imanaka S Biomedicines. 2023; 11(5).

PMID: 37238908 PMC: 10215522. DOI: 10.3390/biomedicines11051237.


Integrative analyses of RNA-seq and ChIP-seq Reveal MITF as a Target Gene of TFPI-2 in MDA231 Cells.

Wang G, Zhang G, Zhu N, Zhu C, Kang M, Zuo G Biochem Genet. 2023; 61(5):1745-1757.

PMID: 36787085 DOI: 10.1007/s10528-023-10340-w.


References
1.
Zhang M, Li M, Sun L . NKLP27: a teleost NK-lysin peptide that modulates immune response, induces degradation of bacterial DNA, and inhibits bacterial and viral infection. PLoS One. 2014; 9(9):e106543. PMC: 4152322. DOI: 10.1371/journal.pone.0106543. View

2.
Zhang Y, Wang L, Zhou W, Wang H, Zhang J, Deng S . Tissue factor pathway inhibitor-2: a novel gene involved in zebrafish central nervous system development. Dev Biol. 2013; 381(1):38-49. DOI: 10.1016/j.ydbio.2013.06.018. View

3.
Sierko E, Wojtukiewicz M, Kisiel W . The role of tissue factor pathway inhibitor-2 in cancer biology. Semin Thromb Hemost. 2007; 33(7):653-9. DOI: 10.1055/s-2007-991532. View

4.
Chand H, Foster D, Kisiel W . Structure, function and biology of tissue factor pathway inhibitor-2. Thromb Haemost. 2006; 94(6):1122-30. DOI: 10.1160/TH05-07-0509. View

5.
Yang D, Zou R, Zhu Y, Liu B, Yao D, Jiang J . Magainin II modified polydiacetylene micelles for cancer therapy. Nanoscale. 2014; 6(24):14772-83. DOI: 10.1039/c4nr04405c. View